With the analysis among 162 patents, we discovered top 51 key players by total patent application. Bristol Myers Squibb Co., Regeneron Pharmaceuticals, Inc., Innovent Biologics (Suzhou) Co. Ltd. are dominant in this area. They take 33.95% of the total patent filing.
New York, United States
Patent: 27
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 18
Innovent Biologics (Suzhou) Co. Ltd.
Jiangsu Sheng, China
Patent: 10
Advanced Proteome Therapeutics, Inc.
Massachusetts, United States
Patent: 7
Shanghai Pharmaceuticals Holding Co., Ltd.
Shanghai Shi, China
Patent: 5
Massachusetts, United States
Patent: 5
Centre National De La Recherche Scientif
GlaxoSmithKline Biologicals SA
KANAPH Therapeutics, Inc.
With the analysis among 15 patents, we discovered top 4 start-ups by total patent application. GI Innovation, Inc., KANAPH Therapeutics, Inc., Hemoglobin Oxygen Therapeutics LLC are active in this area.
KANAPH Therapeutics, Inc.
Hemoglobin Oxygen Therapeutics LLC
Pennsylvania, United States
Patent: 1
Cambridgeshire, United Kingdom
Patent: 1
With the analysis among related 95 patents applied in the last 5 years. We discover 35 most active companies in this area. The fast-growing Regeneron Pharmaceuticals, Inc., Innovent Biologics (Suzhou) Co. Ltd., GI Innovation, Inc. take 38.95% of patent filing during this period.
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 18
Innovent Biologics (Suzhou) Co. Ltd.
Jiangsu Sheng, China
Patent: 10
Agency for Science, Technology & Research
Central Region, Singapore
Patent: 5
Shanghai Pharmaceuticals Holding Co., Ltd.
Shanghai Shi, China
Patent: 5
Guangzhou Leide Bioscience Co., Ltd.
Guangdong Sheng, China
Patent: 4
KANAPH Therapeutics, Inc.
The University of North Carolina at Chapel Hill
North Carolina, United States
Patent: 3
The Brigham & Women's Hospital, Inc.
Massachusetts, United States
Patent: 3
With the analysis among related 95 patents in last 5 years, we discover 32 new entrants. Regeneron Pharmaceuticals, Inc., Innovent Biologics (Suzhou) Co. Ltd., GI Innovation, Inc. are the most active new entrants in this area.
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 18
Innovent Biologics (Suzhou) Co. Ltd.
Jiangsu Sheng, China
Patent: 10
Agency for Science, Technology & Research
Central Region, Singapore
Patent: 5
Shanghai Pharmaceuticals Holding Co., Ltd.
Shanghai Shi, China
Patent: 5
Guangzhou Leide Bioscience Co., Ltd.
Guangdong Sheng, China
Patent: 4
KANAPH Therapeutics, Inc.
The University of North Carolina at Chapel Hill
North Carolina, United States
Patent: 3
The Brigham & Women's Hospital, Inc.
Massachusetts, United States
Patent: 3
With the analysis among 46 patents, we discovered top 11 universities and scientific research institutions by total patent application. The University of North Carolina at Chapel Hill, Korea Institute of Science & Technology, Hokkaido University are dominant in this area. They take 30.43% of the total patent filing.
The University of North Carolina at Chapel Hill
North Carolina, United States
Patent: 3
Korea Institute of Science & Technology
Massachusetts Institute of Technology
Massachusetts, United States
Patent: 1
Institut Teknologi Bandung
Jawa Barat, Indonesia
Patent: 1
Zhejiang Sheng, China
Patent: 1
Chongqing Medical University
Chongqing Shi, China
Patent: 1
Jiangsu Sheng, China
Patent: 1